Paradigm Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-104,325
Closed -$320K 820
2013
Q3
$320K Buy
+104,325
New +$320K 0.05% 401